Status:
COMPLETED
Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study
Lead Sponsor:
Yamaguchi University Hospital
Collaborating Sponsors:
Nakamura Memorial Hospital
Iwate Medical University
Conditions:
Subarachnoid Hemorrhage
Cerebral Vasospasm
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
Cerebral vasospasm following subarachnoid hemorrhage (SAH) is the most common cause of morbidity and mortality. Recent studies indicate that Rho-kinase play an important role in the occurrence of such...
Detailed Description
Cerebral vasospasm occasionally seen after subarachnoid hemorrhage (SAH) due to a ruptured intracranial aneurysm is the most common cause of morbidity and mortality in these cases. Recent studies indi...
Eligibility Criteria
Inclusion
- Subarachnoid hemorrhage (SAH)
- The ruptured cerebral aneurysms conformed by cerebral angiography
- The patients with treated by craniotomy and clip application within 72h after the onset of SAH
Exclusion
- Traumatic or mycotic aneurysms
- A history or complication of serious stroke
- Moya Moya disease
- A history of SAH
- Complication of serious heart or hepatic disease or infection or renal failure
- Malignant tumor
- Patients judged to be inappropriate by physician in charge
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00839449
Start Date
December 1 2004
End Date
December 1 2008
Last Update
September 3 2009
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Ootemachi Hospital
Kitakyushu, Fukuoka, Japan, 803-8543
2
Nakamura Memorial Hospital
Sapporo, Hokkaido, Japan, 060-8570
3
Iwate Medical University
Morioka, Iwate, Japan, 020-8505
4
Tohoku University
Sendai, Miyagi, Japan, 980-8574